EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Evaluation of Abuse Deterrent Formulations of Oxycodone Products: Real-World Data from an Enriched Population of Substance Users Assessed with the Addiction Severity Index-Multimedia Version (ASI-MV®)

Jody L Green iD, Taryn Dailey-Govoni, Suzanne K Vosburg

Journal of Pain Research · 2026-01 · Volume 19 · 1-11

DOI: 10.2147/jpr.s541820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pain Research, 2026-01. Verfasst von Jody L Green und 2 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Behavioral Health, Inflexxion, Irvine, CA, 82614, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The study purpose was to evaluate real-world data on routes of administration (ROAs) employed for nonmedical use (NMU) of XTAMPZA ER compared to other oxycodone extended-release (ER) and oxycodone immediate-release (IR) formulations in a population of adults assessed for substance use. Patients and Methods: A cross-sectional observational study was conducted among adults assessed for substance use and treatment planning using the Addiction Severity Index-Multimedia Version (ASI-MV®) from July 2016 through December 2023. Demographic and substance use history data were summarized to characterize the sample. The primary outcome measure was the prevalence of past 30-day non-oral NMU, assessed first by using Pearson's chi-square to test differences in prevalence, then by calculating the proportional reporting ratios (PRR) to determine if specific non-oral ROAs were more or less likely to be used for XTAMPZA ER NMU versus comparators.

Results

The prevalence of non-oral ROA cases was significantly higher among other oxycodone ER cases (2221/4935, 45.0%) and oxycodone IR cases (10,598/20,394, 52.0%) compared to XTAMPZA ER cases (31/141, 22.0%)(X2=29.43, p

Schlagwörter

Stichwörter der Autor:innen

abuse deterrent formulationsnonmedical useopioidpain managementreal-world dataroutes of administrationsubstance abuse treatment

Autor:innen und Institutionen

  • Integrated Behavioral Health, Inflexxion, Irvine, CA, 82614, USA.

ORCID-Profile: Jody L Green

Zitieren

APA

Green, J. L., Dailey-Govoni, T., & Vosburg, S. K. (2026). Evaluation of Abuse Deterrent Formulations of Oxycodone Products: Real-World Data from an Enriched Population of Substance Users Assessed with the Addiction Severity Index-Multimedia Version (ASI-MV®). Journal of Pain Research, Volume 19, 1-11. https://doi.org/10.2147/jpr.s541820

Vancouver

Green JL, Dailey-Govoni T, Vosburg SK. Evaluation of Abuse Deterrent Formulations of Oxycodone Products: Real-World Data from an Enriched Population of Substance Users Assessed with the Addiction Severity Index-Multimedia Version (ASI-MV®). Journal of Pain Research. 2026;Volume 19:1-11. doi:10.2147/jpr.s541820

BibTeX
@article{Green2026,
  author = {Green, Jody L and Dailey-Govoni, Taryn and Vosburg, Suzanne K},
  title = {Evaluation of Abuse Deterrent Formulations of Oxycodone Products: Real-World Data from an Enriched Population of Substance Users Assessed with the Addiction Severity Index-Multimedia Version (ASI-MV®)},
  journal = {Journal of Pain Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--11},
  doi = {10.2147/jpr.s541820}
}
Kostenlos starten →